2020 Archive

August 29, 2020

Wish	Hemodialysis University 2019    International Society for Hemodialysis Chicago, IL; September 22-23, 2019 PART 4 What’s New in Anemia Management for Hemodialysis? Jay Wish, MD

Agarwal   Daugirdas

Hemodialysis University 2019    International Society for Hemodialysis Chicago, IL; September 22-23, 2019 PART 5 Aspirin and Other Anti-platelet Agents and Vascular Access Anil Agarwal, MD Dosing of Advanced Anti-platelet drugs in coronary syndromes in HD pts Anil Agarwal, MD Modeled Daily Absorbable Phosphorus and Protein Catabolic Rate John Daugirdas, MD

Kotanko   Unruh   Teitelbaum   Kooman

Advances in Chronic Kidney Disease 2020    Renal Research Institute, Los Angeles, CA; January, 2020 PART 1 Welcome/Program Overview Peter Kotanko, MD High quality PD: how can it be achieved? Issac Teitelbaum, MD Why should Uremic Pruritus (UP) and Restless Legs Syndrome (RLS) be diagnosed and treated? Mark Unruh MD Intradialytic hypotension: mechanisms and outcome Jeroen Kooman, MD

Erickson

Harvard Intensive Review of Nephrology 2018    Boston, MA; August, 2018 PART 9 Poisonings and intoxications. What a Nephrologist now Needs to Know? Timothy B. Erickson MD

May 6, 2020

Leehey   Whittier   Agarwal   Yee

Hemodialysis University 2019    International Society for Hemodialysis Chicago, IL; September 22-23, 2019 PART 3 Magnesium Balance During Hemodialysis - Can We Do Better? David J. Leehey, MD Recovery of Renal Function after Starting Dialysis William Luke Whittier, MD Hypertension in Dialysis Patients Rajiv L. Agarwal, MD Treatment of Severe Hyponatremia by CRRT and Hemodialysis Jerry Yee, MD

Grobe   McCausland

Advances in Chronic Kidney Disease 2019    Renal Research Institute, New Orleans, LA; January, 2019 PART 8 How Metabolomics is bound to make an impact in Nephrology? Nadja Grobe, MD Dialysate Sodium Levels - Should we care? Finnian McCausland, MD

Wojciechowski

Harvard Intensive Review of Nephrology 2018    Boston, MA; August, 2018 PART 8 Donor Evaluation David Wojciechowski DO

March 6, 2020

Nigwekar   Tattersall   Lindley

Hemodialysis University 2019    International Society for Hemodialysis Chicago, IL; September 22-23, 2019 PART 2 Impact of Volume Depletion and Volume Overload on Residual Renal Function and Cardiac Function James Tattersall, MD Technology to Assist in Control of Volume Overload Elizabeth J. Lindley, PhD Warfarin vs. Newer Medications for Atrial Fibrillation and Other Indications Sagar Nigwekar, MD

Unruh   Wish   Kooman   Saran

Advances in Chronic Kidney Disease 2019    Renal Research Institute, New Orleans, LA; January, 2019 PARTS 6 and 7 Treatment of Sleep Disorders in CKD - A Practical Approach Mark Unruh, MD Difficult Patient Behavior in Dialysis Facilities Jay Wish, MD Body Fluids in ESRD: Statics and Dynamics Jeroen Kooman, MD Vascular Access: What Nephrologists need to know Arif Asif, MD Arteriovenous Fistula Maturation in HD patients: Why are we doing such a bad job? Rajiv Saran, MD

Steele   Azzi

Harvard Intensive Review of Nephrology 2018    Boston, MA; August, 2018 PARTS 6 and 7 Pre-Transplant Evaluation of Recipients Jamil R. Azzi MD, and Sayeed K. Malek MD Cardiorenal and Hepatorenal Syndromes David J.R. Steele MD

HDCN home /about our site / subscribe to key zone / register for free zone
update email address / subscription status / forget your password?